Dopamine receptor supersensitivity: An outcome and index of neurotoxicity

Neurotoxicity Research

Volumn 5, Issue 1-2, 2003, Pages 111-117

  Kostrzewa, Richard M ^a   Kostrzewa, John P ^a   Brus, Ryszard ^b  

^a East Tennessee State University   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

6 Hydroxydopamine; Dopamine; Neurotoxicity; Receptor priming; Receptor supersensitivity

Indexed keywords

IRON; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; BRAIN; DRUG EFFECT; EXPLORATORY BEHAVIOR; FEMALE; IRON OVERLOAD; MALE; MAZE TEST; MEMORY; METABOLISM; MOTOR ACTIVITY; MOUSE; NEWBORN; OXIDATIVE STRESS; PREGNANCY; PSYCHOLOGICAL ASPECT; RAT; SUBSTANTIA NIGRA; WEIGHT GAIN; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; EXPLORATORY BEHAVIOR; FEMALE; IRON; IRON OVERLOAD; MALE; MAZE LEARNING; MEMORY; MICE; MOTOR ACTIVITY; OXIDATIVE STRESS; PREGNANCY; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; THIOBARBITURIC ACID REACTIVE SUBSTANCES; WEIGHT GAIN;

EID: 0642284616     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033376     Document Type: Article

References (73)

1. Allen SM and WM Davis (1999) Relationship of dopamine to serotonin tonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome. Behav. Pharmacol. 10, 467-474.
2. Berger, TW, S Kaul, EM Stricker and MJ Zigmond (1985) Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain. Res. 336, 354-358.
3. Breese GR and TD Traylor (1972) Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: Effects of 6-hydroxydopamine. Br. J. Pharm. 44, 210-222.
4. Breese GR, AA Baumeister, TJ McCown, SG Emerick, GD Frye, K Crotty and RA Mueller (1984) Behavioural differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharm. Exp. Ther. 231, 313-354.
5. 1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J. Pharm. Exp. Ther. 235, 287-295.
6. 1 dopamine receptors in neonatally lesioned rats. J. Pharm. Exp. Ther. 234, 447-455.
7. 2 -dopamine agonists into the nucleus accumbens and striatum wtihout changing dopamine antagonist binding. J. Pharm. Exp. Ther. 240, 167-176.
8. Breese GR, HE Criswell, GE Duncan and RA Mueller (1990) A dopamine deficiency model of Lesch-Nyhan disease-the neonatal-6-hydroxydopamine-lesioned rat. Brain Res. Bull. 25, 477-484.
9. Brown RW, JT Gass and RM Kostrzewa (2002) Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats. Pharmacol. Biochem. Behav. 72, 591-600.
10. Brus R, RM Kostizewa, KW Perry and RW Fuller (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5.7-dihydroxytryptamine treatment. J. Pharm. Exp. Ther. 268, 231-237.
11. Brus R, A Plech and RM Kostrzewa (1995) Enhanced quinpirole responses in rats lesioned neonatally with 5,7-dihydroxytryptamine. Pharmacol. Biochem. Behav. 50, 649-653.
12. Brus R, R Szkilnik, P Nowak and RM Kostrzewa (1997) Nitro-L-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats. Acta Neurobiol. Exp. 57, 283-287.
13. Castañeda E, IA Whishaw, L Lermer and TE Robinson (1990) Dopamine depletion in neonatal rats: Effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res. 508, 30-39.
14. 2 dopamine receptor mRNA in rat corpus striatum. Dev. Brain Res. 63 95-104.
15. 1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J. Neurosci. 9, 125-133.
16. Descarries, L., J-J Soghomonian, S Garcia, G Doucet and JP Bruno (1992) Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res., 569, 1-13.
17. Descarries L, JP Soucy, F Lafaille, A Mrini and R Tanguay (1995) Evaluation of three transporter ligands as quantitative markers of serotonin innervation density in rat brain. Synapse 21, 131-139.
18. 1 dopamine receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536, 287-296.
19. Duncan GE, HE Criswell, TJ McCown, IA Paul, RA Mueller and GR Breese (1987) Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J. Pharm. Exp. Ther. 243, 1027-1034.
20. 1 receptors during postnatal development. J. Neurosci 61, 1255-1262.
21. El Mansari M, F Radja, A Ferron, TA Reader, E Molina-Holgado and L Descarries (1994) Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation. Eur. J. Pharm. 261, 171-178.
22. Fernandes Xavier, F.G., Doucet, G., Geffard, M. and Descarries, L. (1994) Dopamine neoinnervation in the substantia nigra and hyperinnervation in the interpeduncular nucleus of adult rat following neonatal cerebroventriculara administration of 6-hydroxy-dopamine. Neuroscience 59, 77-87.
23. 1 receptor development depends on endogenous dopamine. Dev. Brain Res. 56, 137-140.
24. Gong L and RM Kostrzewa (1992) Supersensitized oral response to a serotonin agonist in neonatal 6-OHDA treated rats. Pharmacol. Biochem. Behav. 41, 621-623.
25. Gong, I, RM Kostrzewa, RW Fuller and KW Perry (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6 OHDA-lesioned rats is mediated through a serotonin system. J. Pharm. Exp. Ther. 261, 1000-1007.
26. 1 recepters in neonatal 6-OHDA-lesioned rats. Dev. Brain Res. 76, 59-65.
27. Gong L, RM Kostrezewa, KW Perry and RW Fuller (1993b) Doserelated effects of a neonatal 6-OHDA lesion on SKF 38393- and m -chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76, 233-238.
28. 2 receptor mRNA levels: Absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. J. Neurochem. 63, 1282-1290.
29. Gunne, LM, U Andersson, U Bondesson and P Johansson (1986) Spontaneous movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav. 25, 897-901.
30. 2 receptors. Eur. J. Pharmacol. 203, 115-120.
31. 3H]raclopride binding to neostriatal homogenates. J. Pharm. Exp. ther. 280, 268-276.
32. Jackson D and ED Abercrombie (1992) In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of depamine at infancy. J. Neurochem. 58, 890-897.
33. 1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: Behavioral effects and induction of c-fos-like immunoreactivity. J. Pharm. Exp. Ther. 262, 855-865.
34. Kasperska A, R Brus, R Szkilnik, J Oświecimska, RM Kostrzewa and J Shani (1999) Modulation of central dopamine receptor reactivity in the rat, by nitric oxide donors and inhibitor: Behavioral studies. Pharmacol Rev. Commun. 10, 311-319.
35. Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19, 1-17.
36. Kostrzewa RM and R Brus (1991) Ontogenic homologous supersensitization of quinpirole-induced yawning in rats. Pharmacol. Biochem. Behav. 39, 517-519.
37. 1 receptors mediate enhanced oral activity after neonatal 6-OHDA. Pharmacol. Biochem. Behav. 39, 677-682.
38. Kostrzewa, RM, and A Hamdi (1991) Potentiation of spiroperidol-induced oral activity in rats after neonatal 6-hydroxydopamine. Phamracol. Biochem. Behav. 38, 215-218.
39. Kostrzewa RM and Haper JW (1974) Effect of 6-hydroxydopa on catecholamine-containing neurons in brains of newborn rats. Brain Res. 69, 174-181.
40. Kostrzewa RM and N-Y Huang (1997) Serotonin antagonists attenuate oral dyskinesias in 6-hydroxydopamine-lesioned rats during withdrawal from chronic haloperidol. The Pharmacologists 39, 120.
41. 2 receptors. Eur. J. Pharmacol. 183, 1411-1412.
42. Kostrzewa RM, R Brus and J Kalbfleisch (1991) Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats. Eur. J. Pharmacol. 209, 157-161.
43. Kostrzewa RM, L Gong and R Brus (1992) Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. Acta Neurobiol. Exp. 53, 31-41.
44. Kostrzewa RM, R Brus, KW Perry and RW Fuller (1993a) Agedependence of a 6-hydroxy-dopamine lesion of SKF 38393-and m -chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76, 87-93.
45. Kostrzewa RM, R Brus, M Rykaczewska and A Plech (1993b) Low dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats. Pharmacol. Biochem. Behav. 44, 487-489.
46. Kostrzewa RM, J Guo and FP Kostrzewa (1993c) Ontogenetic quinpirole treatments induce vertical jumping activity in rats. Eur. J. Pharmacol. 239, 183-187.
47. Kostrzewa RM, R Brus, JH Kalbflesich, KW Perry and RW Fuller (1994) Proposed animal model of attention deficit hyperactivity disorder. Brain Res. Bull. 34, 161-167.
48. Kostrzewa RM, R Brus, KW Perry and RW Fuller (1996) Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content. Acta Neurobiol. Exp. 56, 21-28.
49. Kostrzewa RM, TA Reader and L. Descarries (1998) Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain. J. Neurochem. 70, 889-898.
50. Kostrzewa RM, R Brus and KW Perry (1999) Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system. Pol. J. Pharmacol. 5, 39-47.
51. Luthman J, B Bolioli, T Tsutsumi, A Verhofstad and G Jonsson (1987) Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res. Bull. 19, 269-274.
52. Luthman J, E Lindqvist, D Young and R Cowburn (1999) Neonatal dopamine lesion in the rat results in enhanced adenvlate cyclase activity without altering dopamine receptor binding or dopamine and adenosine 3′-5′ monophosphate regulated (DARPP-32) immunoreactivity. Exp. Brain Res. 83, 85-95.
53. Lytle LD, WJ Shoemaker, K Cottman and RJ Wurtman (1972) Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels. J. Pharm. Exp. Ther. 183, 56-64.
54. Mailman RB, A Towle, DW Shulz, Mh Lewis, GR Breese, DL DeHaven and MR Krigman (1983) Neonatal 6-OHDA treatment of rats: Changes in dopamine (DA) receptors, striatal neurochemistry and anatomy. Soc. Neurosci. Abstr. 9, 932.
55. Mithani S, S Atmadja, KG Baimbridge and HC Fibiger (1987) Neuroleptic-induced oral dyskinesias: Effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology (Berlin) 93, 94-100.
56. Molina-Holgado E, K Dewar, L Descarries and TA Reader (1994) Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J. Pharm. Exp. Ther. 270, 713-721.
57. Mrini A, J-P Soucy, F Lafaille, P Lemoine and L Descarries (1995) Quantification of the serotonin hyperinnervation in adult rat neostriatum after neonatal 6-hydroxydopamine lesion of nigral dopamine neurons. Brain Res. 669, 303-308.
58. Nowak P, R Brus and RM Kostrzewa (2001) Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol. J. Pharmacol. 53, 319-329.
59. O'swiecimska J, R Brus, R Szkilnik, P Nowak and RM Kostrzewa (2000) 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats. Pharmacol. Biochem. Behav. 67, 11-15.
60. Plech A, R Brus, JH Kalbfleisch and RM Kostrzewa (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology (Berlin) 119, 466-473.
61. 2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: A quantitative autoradiographic study. Brain Res. 606, 273-285.
62. 2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis. Neuroscience 57, 635-648.
63. Sachs C and G Jonsson (1972) Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals. Res. Commun. Chem. Pathol. Pharmacol. 4, 203-220.
64. 1 -dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat. J. Pharm. Exp. Ther. 263, 1454-1463.
65. Snyder AM, MJ Zigmond and RD Lund (1986) Sprouting of serotonin afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J. Comp. Neurol. 245, 274-281.
66. Soucy JP, F Lafaille, P Lemoine, A Mrini and L Descarries (1994) Validation of the transporter ligand cyanoimipramine as a marker of serotonin innervation density in rat brain. J. Nucl. Med. 35, 1822-1830.
67. Stachowiak MK, JP Bruno, AM Snyder, EM Stricker and MJ Zigmond (1984) Apparent sprouting of striatal serotoninergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291, 164-167.
68. Szechtman H, H Dal, S Mustafa, H Einat and RM Sullivan (1994) Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole. Pharmacol. Biochem. Behav. 48, 921-928.
69. Szechtman H, W Sulis and D Eilam (1998) Quinpirole induces compulsive checking behavior in rats: A potential animal model of obsessive compulsive disorder (OCD). Behav. Neurosci. 112, 1475-1485.
70. Tamminga CA, JM Dale, L Goodman, H Kaneda and N Kaneda (1990) Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: A study in three rat strains. Psychopharmacology (Berlin) 102, 474-478.
71. Tizabi Y, RL Copeland Jr, R Brus and RM Kostrzewa (1999) Nicotine blocks quinpirole-induced behavior in rats: Psychiatric implications. Psychopharmacology (Berlin) 145, 433-441.
72. Tizabi Y, VA Louis, CT Taylor, D Waxman, KE Culver and H Szechtman (2002) Effect of nicotine on quinpirole-induced checking behavior in rats: Implications for obsessive-compulsive disorder. Biol. Psychiatry 51, 164-171.
73. Towle AG, HE Criswell, EH Maynard, JM Lauder, TH Joh, RA Mueller and GR Breese (1989) Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: An anatomical, biochemical and pharmacological study. Pharmacol. Biochem. Behav. 34, 367-374.